Use of agonists of type-2 dopaminergic receptors in treatment of conditions caused by elevated vascular endothelial growth factor levels

• 收藏
• 分享

专利权人:

OFTA SP.ZO.O.

发明人:

OSEKA Maciej (PL)

申请号：

IL25990318

公开号：

IL259903D0

申请日:

2018.06.07

申请国别(地区):

IL

年份:

2018

代理人:

摘要：

The present invention relates to a use of type-2 dopaminergic receptor agonists in treatment of eye diseases caused by an elevated level of vascular endothelial growth factor (VEGF), particularly in treatment or prevention of diseases of an eye retina resulting from an increase in permeability of blood vessels and their angiogenesis using cabergoline, a dopaminergic D2 receptor agonist.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/